Optimization of [11C]DASB-synthesis: Vessel-based and Flow-through Microreactor Methods
Overview
Nuclear Medicine
Authors
Affiliations
The intention for the present study was to implement a microfluidic set-up for N-(11)C-methylations in a flow-through microreactor device with [(11)C]DASB as model-compound and [(11)C]CH(3)I and [(11)C]CH(3)OTf, respectively, as (11)C-methylation agents. Due to an observed "aging" effect of the (11)C-methylation agents' solution, this goal was not achieved. Nevertheless, based on these observations, the time consumption for the vessel-based routine production of [(11)C]DASB was reduced (34±1 min) and RCY was increased to 45.1±4.6% (EOB; 5.2±0.95 GBq EOS).
Fonseca I, Pais M, Rodrigues F, Sereno J, Castelo-Branco M, Cavadas C Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675435 PMC: 11053772. DOI: 10.3390/ph17040474.
A rapid and systematic approach for the optimization of radio thin-layer chromatography resolution.
Laferriere-Holloway T, Rios A, Lu Y, Okoro C, van Dam R J Chromatogr A. 2022; 1687:463656.
PMID: 36463649 PMC: 9894532. DOI: 10.1016/j.chroma.2022.463656.
Microliter-scale reaction arrays for economical high-throughput experimentation in radiochemistry.
Rios A, Holloway T, Chao P, De Caro C, Okoro C, van Dam R Sci Rep. 2022; 12(1):10263.
PMID: 35715457 PMC: 9205965. DOI: 10.1038/s41598-022-14022-2.
Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production.
Frank C, Winter G, Rensei F, Samper V, Brooks A, Hockley B EJNMMI Radiopharm Chem. 2019; 4(1):24.
PMID: 31659546 PMC: 6751239. DOI: 10.1186/s41181-019-0077-0.
Spies M, James G, Berroteran-Infante N, Ibeschitz H, Kranz G, Unterholzner J Int J Neuropsychopharmacol. 2017; 21(2):145-153.
PMID: 29045739 PMC: 5793827. DOI: 10.1093/ijnp/pyx085.